Given that the expression of CDCP1 is temporally upregulated under pathological conditions such as tissue injury, hypoxia, and cancer recurrence (32), it is likely that upregulated CDCP1 may function to acutely amplify the HGF signaling that is required for regenerative organ growth in critical situations. The gene discussed is CDCP1; the disease is cancer.